ABAmi Shah Brown

Ami Shah Brown

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ami Shah Brown has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Maria Elena Bottazzi

    Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, USA

    1 shared publication
  • Peter Jay Hotez

    Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; James A Baker III Institute of Public Policy, Rice University, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA

    1 shared publication

Latest Publications

  • Neglected tropical disease vaccines

    by Peter J. Hotez, Ami Shah Brown


  • Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm

    by Maria Elena Bottazzi, Ami Shah Brown

    This article provides an overview of the advances in product development and technology transfer of the vaccine against human hookworm, with particular emphasis on the lessons learned and the challenges of developing a vaccine in the nonprofit sector. The comprehensive approach to vaccine development established by the Human Hookworm Vaccine Initiative (HHVI) identifies key operational and technical aspects that are essential for a successful partnership with a developing country vaccine manufacturer. This article also highlights the importance of a global access roadmap to guide the vaccine development program. The advancement of new products for the control of neglected tropical diseases portends great challenges for global access, including aspects related to vaccine design, product development and manufacture, vaccine introduction and distribution, financing, knowledge dissemination and intellectual property management. With only three vaccines for neglected tropical diseases in clinical trials - hookworm, leishmaniasis and schistosomiasis - we are at the nascent stages of developing vaccines for neglected populations. Product development public-private partnerships, such as the HHVI, continue to show great promise on this front and will eventually provide significant control tools for achieving millennium development goals related to poverty reduction, as well as child and maternal health.